D-Target definition

D-Target means a protein composed of D amino acids.
Sample 1

Examples of D-Target in a sentence

  • We also find that this result is not very sensitive to the assignment of the reaction re- versibility during genome-scale metabolic reconstructions (SI Text, section III, D).Target Observability.

  • DTarget , on the other hand,AAWe define our attack model as a supervised ML classifier with binary classes (member or non-member).

  • For each dataset, we first split it by half into DShadow and DTarget .

  • EBL2 ON DTarget tracked hereInitial target position Predicting collision course with the offset EBL2.17.2 Measuring range & bearing between two targetsThe procedure which follows shows how to measure the range and bearing between two targets, using the targets “A” and “B” in the figure below as an example.

  • This law contains minimum standards of conduct to ensure that there are no conflicts between an employee’s official duties and the employee’s personal interests.

  • After removing the TUs that contain only numbers, dates, or punctuation symbols, 292,258 TUs were left.TM ATM BTM CTM DTarget LanguageGermanJapaneseGermanJapaneseTotal TUs2296118799301583298700Total less TUs containing only numbers or punctuation2250318650293924292258 Table 4.3 Overview of TM Data For TMs C and D, a sample of 50,000 TUs was studied.

  • Additional information:I -DTarget populationI - EGeographic areaI - FProbable funding amountsII - DSingle or multiple awardsIII - AService activitiesIII – B - 5Reporting requirementsIII – B - 7Unit of service/unit rate • After-the-fact secondary purchases will be allowed.

  • Algorithm 1 Proposed method (fitness & novelty)Require: Target, SynthesizerInitialize Population as list of random Individuals Initialize Archive as empty listfor gen = 1, ··· , Ngen dofor ind ∈ Population do Evaluation of Individuals audio ← Synthesizer(ind.gtype)ind.fitness ← −LS D(Target, audio) ind.bc ← BC(audio)for ind ∈ Population do Novelty calculationreal-valued genetic operators that have been shown to be more effective in continuous domains than discretized methods [28].

  • Indeed, it shows the low sensitivity of project developers to the weight of bank interest, and the probable existence of non-financial obstacles49 that a GSF would not over- come.

  • Flip chart: Ask the participants:▲ What types of recommendations would they normally include for such attributes in Schedule C of a spacing contract?List these.▲ Point out that in the SMP the management of these attributes should also be explained in section D-Target Stand Strategy for the appropriate SU.

Related to D-Target

  • Soft Target means a target that will suffer minimum damage and cause minimum damage to the subject vehicle in the event of a collision.

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Acquisition Target means any Person becoming a Subsidiary of the Company after the date hereof; any Person that is merged into or consolidated with the Company or any Subsidiary of the Company after the date hereof; or any Person with respect to which all or a substantial part of that Person’s assets are acquired by the Company or any Subsidiary of the Company after the date hereof.

  • EBITDA Target means the Company's projected earnings before interest, taxes, one-time transition expenses, non-cash compensation expense charges, depreciation and amortization, as contained in the Company's budget for the Applicable Period and which is approved by the Board (without reference to any adjustments or revision, upwards or downwards, to such projected earnings which are subsequently approved by the Board as part of any subsequent revision to such budget), and (ii) the term "Financial Results" shall mean the Company's EBITDA calculated by reference to the Company's financial statements for the Applicable Period as filed with the Securities and Exchange Commission (the "SEC").

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Third Target Distribution means $0.5250 per Unit per Quarter (or, with respect to the period commencing on the Closing Date and ending on September 30, 2005, it means the product of $0.5250 multiplied by a fraction of which the numerator is equal to the number of days in such period and of which the denominator is 92), subject to adjustment in accordance with Section 6.6 and Section 6.9.

  • Development Milestone Event has the meaning set forth in Section 7.1.

  • Second Target Distribution means $0.4375 per Unit per Quarter (or, with respect to the period commencing on the Closing Date and ending on September 30, 2005, it means the product of $0.4375 multiplied by a fraction of which the numerator is equal to the number of days in such period and of which the denominator is 92), subject to adjustment in accordance with Section 6.6 and Section 6.9.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • M2 Target Amount With respect to any Distribution Date, an amount equal to the lesser of (a) the product of (i) 65.70% minus the Additional Required Enhancement Percentage and (ii) the Pool Balance for such Distribution Date determined as of the last day of the related Collection Period and (b) the amount, if any, by which (i) the Pool Balance for such Distribution Date determined as of the last day of the related Collection Period exceeds (ii) 0.50% of the Cut-off Date Balance.

  • M1 Target Amount With respect to any Distribution Date, an amount equal to the lesser of (a) the product of (i) 70.00% and (ii) the Pool Balance for such Distribution Date and (b) the amount, if any, by which (i) the Pool Balance for such Distribution Date exceeds (ii) 0.50% of the Cut-off Date Balance.

  • M4 Target Amount With respect to any Distribution Date, an amount equal to the lesser of (a) the product of (i) 95.30% and (ii) the Aggregate Loan Balance for such Distribution Date determined as of the last day of the related Collection Period and (b) the amount, if any, by which (i) the Aggregate Loan Balance for such Distribution Date determined as of the last day of the related Collection Period exceeds (ii) 0.50% of the Cut-off Date Balance.

  • M5 Target Amount With respect to any Distribution Date an amount equal to the lesser of (a) the product of (i) 93.30% and (ii) the Aggregate Loan Balance for such Distribution Date determined as of the last day of the related Collection Period and (b) the amount, if any, by which (1) the Aggregate Loan Balance for such Distribution Date determined as of the last day of the related Collection Period exceeds (2) the Overcollateralization Floor.

  • continuing candidate means any candidate not deemed to be elected, and not excluded,

  • Antigen means a substance recognized by the body as being foreign; it results in the production of specific antibodies directed against it.

  • M3 Target Amount With respect to any Distribution Date, an amount equal to the lesser of (a) the product of (i) 85.50% and (ii) the Pool Balance for such Distribution Date and (b) the amount, if any, by which (i) the Pool Balance for such Distribution Date exceeds (ii) 0.50% of the Cut-off Date Balance.

  • Milestone Event has the meaning set forth in Section 8.4.

  • Bonus Target means the annual bonus that the Executive would have received in a fiscal year under the AIP Plan and/or the EIC Plan, if the target goals had been achieved.

  • hit means the existence of a match or matches established by the Central System by comparison between biometric […] data recorded in the computerised central database and those transmitted by a Member State with regard to a person, without prejudice to the requirement that Member States shall immediately check the results of the comparison pursuant to Article 26(4);

  • Sanctioned Target means any target of Sanctions, including (i) persons on any list of targets identified or designated pursuant to any Sanctions, (ii) persons, countries, or territories that are the target of any territorial or country-based Sanctions program, (iii) persons that are a target of Sanctions due to their ownership or control by any Sanctioned Target(s), or (iv) persons otherwise a target of Sanctions, including vessels and aircraft, that are designated under any Sanctions program.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • GSK will have the meaning set forth in the Preamble.